Management of fetal and neonatal alloimmune thrombocytopenia.
INTS, Paris, France.
C
C
Kaplan
F
F
Daffos
F
F
Forestier
M C
MC
Morel-Kopp
G
G
Tchernia
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D016824:Antigens, Human Platelet / Q000276:immunology; D001805:Blood Transfusion, Intrauterine; D003131:Combined Modality Therapy; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D005315:Fetal Diseases / Q000276:immunology / Q000628:therapy*; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007112:Immunity, Maternally-Acquired; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007231:Infant, Newborn; D007518:Isoantibodies / Q000276:immunology; D008431:Maternal-Fetal Exchange; D017713:Platelet Transfusion; D011247:Pregnancy; D013921:Thrombocytopenia / Q000151:congenital / Q000196:embryology / Q000276:immunology / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D016824:Antigens, Human Platelet; D016756:Immunoglobulins, Intravenous; D007518:Isoantibodies